FDA found Albek de Mexico hand sanitizer contained methanol instead of labeled ethanol and was adulterated, unapproved, and misbranded.
What happened
FDA laboratory testing of batches of NEXT ADVANCED ANTIBACTERIAL HAND SANITIZER detained at the U.S. border found the product declared to be made at Albek de Mexico's facility contained less ethanol than the labeled 70% v/v and significant methanol (10% to 29% v/v). The product was refused admission, and the company recalled it nationwide on July 31, 2020.
What FDA found
FDA found the labeled active ingredient ethanol was substituted in part with methanol, making the hand sanitizer adulterated.
FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)The substitution shows quality assurance at the facility did not meet CGMP.
FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)FDA says the hand sanitizer is an unapproved new drug sold without an approved application.
FD&C Act sections 505(a) and 301(d); 21 U.S.C. 355(a), 331(d)FDA says the product is dangerous to health when used as labeled because it contains methanol.
FD&C Act section 502(j), 21 U.S.C. 352(j)FDA says the label falsely states 70% ethanol and does not disclose methanol.
FD&C Act sections 502(a) and 502(e)(1)(A); 21 U.S.C. 352(a), 352(e)(1)(A)FDA says the product does not meet the conditions for marketing under section 505G without an approved application.
FD&C Act section 502(ee), 21 U.S.C. 352(ee)
What FDA wants
FDA asks the company to respond in writing within 15 working days with a detailed investigation, raw material and batch lists, batch records, test methods, corrective actions, and an independent assessment of its laboratory practices. FDA also recommends a qualified CGMP consultant if the firm intends to resume making drugs for the U.S. market.
Who should pay attention
- hand sanitizer brands and distributors sourcing from this manufacturer
- retailers and consumers checking recalled hand sanitizer
- drug makers that rely on supplier certificates for ethanol purity
This is a summary. Read the original letter on fda.gov.